ATE200028T1 - Transdermale abgabe vorrichtung - Google Patents

Transdermale abgabe vorrichtung

Info

Publication number
ATE200028T1
ATE200028T1 AT95901816T AT95901816T ATE200028T1 AT E200028 T1 ATE200028 T1 AT E200028T1 AT 95901816 T AT95901816 T AT 95901816T AT 95901816 T AT95901816 T AT 95901816T AT E200028 T1 ATE200028 T1 AT E200028T1
Authority
AT
Austria
Prior art keywords
methyl
delivery device
transdermal delivery
isoxazole
pyrrolidinyl
Prior art date
Application number
AT95901816T
Other languages
English (en)
Inventor
Timothy A Peterson
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Application granted granted Critical
Publication of ATE200028T1 publication Critical patent/ATE200028T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95901816T 1993-12-08 1994-11-08 Transdermale abgabe vorrichtung ATE200028T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/164,054 US5494680A (en) 1993-12-08 1993-12-08 Transdermal delivery device
PCT/US1994/012854 WO1995015754A1 (en) 1993-12-08 1994-11-08 Transdermal delivery device

Publications (1)

Publication Number Publication Date
ATE200028T1 true ATE200028T1 (de) 2001-04-15

Family

ID=22592782

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95901816T ATE200028T1 (de) 1993-12-08 1994-11-08 Transdermale abgabe vorrichtung

Country Status (15)

Country Link
US (2) US5494680A (de)
EP (1) EP0732922B1 (de)
JP (1) JPH09506365A (de)
CN (1) CN1081459C (de)
AT (1) ATE200028T1 (de)
AU (1) AU678873B2 (de)
CA (1) CA2177588A1 (de)
DE (1) DE69426988T2 (de)
DK (1) DK0732922T3 (de)
ES (1) ES2158067T3 (de)
GR (1) GR3036144T3 (de)
IL (1) IL111648A (de)
NZ (1) NZ276597A (de)
PT (1) PT732922E (de)
WO (1) WO1995015754A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19501022C1 (de) * 1995-01-14 1996-06-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung
AU719171B2 (en) * 1995-01-14 2000-05-04 Abbott Laboratories A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts
US5730721A (en) 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
TW526066B (en) * 1996-12-27 2003-04-01 Kimberly Clark Co Stable and breathable films of improved toughness, their products, and the method of making the same
US6015764A (en) 1996-12-27 2000-01-18 Kimberly-Clark Worldwide, Inc. Microporous elastomeric film/nonwoven breathable laminate and method for making the same
US6111163A (en) 1996-12-27 2000-08-29 Kimberly-Clark Worldwide, Inc. Elastomeric film and method for making the same
US6312715B1 (en) 1998-05-01 2001-11-06 3M Innovative Properties Company Adhesive microsphere drug delivery composition
US6259730B1 (en) 1998-11-10 2001-07-10 Lucent Technologies, Inc. Transmit diversity and reception equalization for radio links
US6337328B1 (en) 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
KR20010036685A (ko) * 1999-10-11 2001-05-07 김윤 펜타닐을 함유하는 매트릭스형 경피투여제
JP4358978B2 (ja) * 2000-09-05 2009-11-04 日東電工株式会社 経皮吸収製剤
CN100340237C (zh) * 2000-11-06 2007-10-03 株式会社三养社 吸水性和粘附性能改善的经皮给药系统
FR2822711B1 (fr) * 2001-03-28 2003-06-13 Oreal Dispositif de traitement comportant une enveloppe definissant une cavite dans laquelle peut-etre engagee une partie du corps
JP2005502430A (ja) * 2001-09-14 2005-01-27 スリーエム イノベイティブ プロパティズ カンパニー 医療用感圧接着物品を製造するための非接触印刷法
US6893655B2 (en) 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
AR033748A1 (es) * 2002-05-15 2004-01-07 Thalas Group Inc Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
DE10231296A1 (de) 2002-07-10 2004-01-22 Basf Ag Verfahren zur Entfernung von Wasser aus einer Mischung, die Wasser und Zinkchlorid enthält
AU2003268376A1 (en) * 2002-08-30 2004-11-26 Watson Pharmaceuticals, Inc. Transdermal delivery systems and methods
EP1613297B1 (de) * 2003-04-14 2007-06-06 LTS Lohmann Therapie-Systeme AG Therapeutisches pflaster mit capsaicin-haltiger polysiloxan-matrix
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
US7182955B2 (en) * 2003-04-30 2007-02-27 3M Innovative Properties Company Abuse-resistant transdermal dosage form
CL2004000927A1 (es) 2003-04-30 2005-01-28 Purdue Pharma Lp Forma de dosificacion transdermica que comprende un agente activo, una superficie proxima y una superficie distal.
US20040219195A1 (en) * 2003-04-30 2004-11-04 3M Innovative Properties Company Abuse-resistant transdermal dosage form
US20050037194A1 (en) * 2003-08-15 2005-02-17 Kimberly-Clark Worldwide, Inc. Thermoplastic polymers with thermally reversible and non-reversible linkages, and articles using same
US20050065062A1 (en) * 2003-09-24 2005-03-24 3M Innovative Properties Company Method of formulating a pharmaceutical composition
US20070269522A1 (en) * 2004-08-20 2007-11-22 Wold Chad R Transdermal Drug Delivery Device with Translucent Protective Film
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
US8287923B2 (en) * 2005-06-10 2012-10-16 Medical College Of Georgia Research Institute, Inc. Compositions and methods for treating immune disorders
US9446017B2 (en) 2005-08-11 2016-09-20 Augusta University Research Institute, Inc. Compositions and methods for treating herpes simplex virus
US9114133B2 (en) 2006-08-25 2015-08-25 U.S. Dept. Of Veterans Affairs Method of improving diastolic dysfunction
DE102007058504A1 (de) 2007-12-05 2009-07-09 Acino Ag Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)
MX2010012989A (es) * 2008-05-30 2011-04-27 Mylan Inc Sistema de suministro de farmaco transdermico estabilizado.
WO2011014775A1 (en) 2009-07-31 2011-02-03 The Brigham And Women's Hospital, Inc. Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
AU2011237592B2 (en) 2010-04-08 2016-10-27 Emory University Substituted androst-4-ene diones
CN102486632A (zh) * 2010-12-01 2012-06-06 中国石油化工股份有限公司 一种对二甲苯氧化过程中对苯二甲酸结晶粒径在线分析方法
US9585930B2 (en) 2011-03-20 2017-03-07 Trustees Of Boston University Therapeutic agent for emphysema and COPD
EP2704726B1 (de) 2011-05-04 2018-10-31 Trustees of Boston University Protonenantriebskraftstimulation zur potenzierung von aminoglycosid-antibiotika gegen persistente bakterien
US20140227293A1 (en) 2011-06-30 2014-08-14 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
EP2543370A1 (de) 2011-07-06 2013-01-09 Georgia Health Sciences University Research Institute, Inc. Zusammensetzungen und Verfahren zur Behandlung des Herpes-simplex-Virus
WO2013071049A1 (en) 2011-11-10 2013-05-16 Trustees Of Boston College Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
US20150366890A1 (en) 2013-02-25 2015-12-24 Trustees Of Boston University Compositions and methods for treating fungal infections
EP3036226B1 (de) 2013-08-22 2020-01-08 The General Hospital Corporation Hemmer der humanen 12/15-lipoxygenase
EP3038625A4 (de) 2013-08-29 2017-08-23 Trustees of Boston University Stoffwechselzwischenprodukte zur potenzierung von aminoglycosid-antibiotika bei bakteriellen infektionen
US10010543B1 (en) 2014-12-23 2018-07-03 Barr Laboratories, Inc. Transdermal dosage form
US9486927B1 (en) 2015-05-20 2016-11-08 Google Inc. Robotic gripper with multiple pairs of gripping fingers
EP3303286B1 (de) 2015-06-01 2023-10-04 Cedars-Sinai Medical Center An rela von nf-kb anbindende verbindungen zur verwendung bei der behandlung von krebs
MX2018001075A (es) 2015-07-28 2019-04-15 Vyome Therapeutics Ltd Agentes terapeuticos y profilacticos antibacterianos.
WO2020009685A1 (en) 2018-07-02 2020-01-09 John Tang Transdermal dosage form
WO2020008370A1 (en) 2018-07-02 2020-01-09 Clexio Biosciences Ltd. Transdermal patch
WO2020008366A1 (en) 2018-07-02 2020-01-09 Clexio Biosciences Ltd. Transdermal dosage form
CN117202878A (zh) 2020-04-30 2023-12-08 金德瓦药物控释有限公司 粘合剂制品及其制备方法
WO2022010864A1 (en) 2020-07-06 2022-01-13 Kindeva Drug Delivery L.P. Drug delivery device for delivery of clobetasol propionate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060084A (en) * 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
JPS61293911A (ja) * 1985-06-24 1986-12-24 Teisan Seiyaku Kk 徐放化製剤
US4880633A (en) * 1986-03-12 1989-11-14 Merck & Co., Inc. Transdermal drug delivery system
US5006342A (en) * 1986-12-22 1991-04-09 Cygnus Corporation Resilient transdermal drug delivery device
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US5176917A (en) * 1989-03-15 1993-01-05 Lts Lohmann Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
ATE197454T1 (de) * 1991-05-29 2000-11-11 Abbott Lab Isoxazol- und isothiazolverbindungen, die die kognitiven funktionen verbesseren

Also Published As

Publication number Publication date
CN1136773A (zh) 1996-11-27
NZ276597A (en) 1997-06-24
DK0732922T3 (da) 2001-07-30
WO1995015754A1 (en) 1995-06-15
AU678873B2 (en) 1997-06-12
EP0732922B1 (de) 2001-03-28
DE69426988D1 (de) 2001-05-03
IL111648A (en) 1997-09-30
GR3036144T3 (en) 2001-09-28
JPH09506365A (ja) 1997-06-24
US5585111A (en) 1996-12-17
DE69426988T2 (de) 2001-11-15
CN1081459C (zh) 2002-03-27
IL111648A0 (en) 1995-01-24
ES2158067T3 (es) 2001-09-01
AU1091395A (en) 1995-06-27
CA2177588A1 (en) 1995-06-15
EP0732922A1 (de) 1996-09-25
US5494680A (en) 1996-02-27
PT732922E (pt) 2001-09-28

Similar Documents

Publication Publication Date Title
ATE200028T1 (de) Transdermale abgabe vorrichtung
MY113685A (en) Transdermal device for the delivery of flurbiprofen
ES2147858T3 (es) Matriz para el suministro transdermico de farmacos.
BR9710738A (pt) Matriz para administrar medicamentos transdermalmente para co-administra-Æo de estradiol e outro esterÄide
NZ316026A (en) A transdermal therapeutic system (a hormone patch) in which drugs are contained which are released into the skin comprising a backing film and a pressure sensitive adhesive
ATE357197T1 (de) Dünnfilmpflaster mit absorberkante
DE69829961D1 (de) Transdermale vorrichtung zur verabreichungvon von testosteron
ES2188907T3 (es) Dispositivo de soporte farmaceutico adecuado ppara la administracion de compuestos farmaceuticos a las superficies de las mucosas.
ATE209940T1 (de) Verbesserte transdermale vorrichtung mit verringerter delaminierung
AU1652997A (en) Transdermal therapeutic systems containing crystallization inhibitors
DK0596903T3 (da) Transdermale, terapeutiske systemer.
NO973548L (no) Behandling av diabetisk neuropati
ATE199496T1 (de) Transdermale darreichungsform mit antihistaminisch wirksamen loratidinmetabolit
LV10749A (lv) Transdermala terapeitiska sistema fizostigmina uzliksanai uz adas un tas izgatavosanas panemiens
ATE289818T1 (de) Transdermales therapeutisches system mit einer östriol enthaltenden bisphosphatekombination

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee